Vbx-016

N/A

Report date: 2025/02/06 10:15:56

Base Information

Drug NameVbx-016

Drug Alias NameVbx-016

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionTelomerase reverse transcriptase inhibitorsMelanoma-specific antigens inhibitorsReceptor protein-tyrosine kinase erbB-2 antagonists +[4]

TargetsTelomerase reverse transcriptaseMelanoma-specific antigensReceptor protein-tyrosine kinase erbB-2 +[4]

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVaxon Biotech

China Registration ClassN/A

Develop Information

Active CompaniesVaxon Biotech

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A